CA2587797A1 - Novel lincomycin derivatives possessing antibacterial activity - Google Patents
Novel lincomycin derivatives possessing antibacterial activity Download PDFInfo
- Publication number
- CA2587797A1 CA2587797A1 CA002587797A CA2587797A CA2587797A1 CA 2587797 A1 CA2587797 A1 CA 2587797A1 CA 002587797 A CA002587797 A CA 002587797A CA 2587797 A CA2587797 A CA 2587797A CA 2587797 A1 CA2587797 A1 CA 2587797A1
- Authority
- CA
- Canada
- Prior art keywords
- substituted
- alkyl
- methyl
- propyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical class CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 title abstract description 19
- 230000000844 anti-bacterial effect Effects 0.000 title abstract description 8
- 150000001875 compounds Chemical class 0.000 claims abstract description 482
- -1 5-methyl-[1,3]dioxol-2-one-4-yl-methoxy-carbonyl Chemical group 0.000 claims description 376
- 229910052739 hydrogen Inorganic materials 0.000 claims description 304
- 239000000651 prodrug Substances 0.000 claims description 107
- 229940002612 prodrug Drugs 0.000 claims description 107
- 125000005843 halogen group Chemical group 0.000 claims description 97
- 229910052736 halogen Inorganic materials 0.000 claims description 83
- 150000003839 salts Chemical class 0.000 claims description 58
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 18
- 229910002091 carbon monoxide Inorganic materials 0.000 claims description 16
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 13
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 7
- 229910052801 chlorine Inorganic materials 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 abstract description 73
- 238000003786 synthesis reaction Methods 0.000 abstract description 67
- 238000000034 method Methods 0.000 abstract description 64
- 241000894006 Bacteria Species 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 8
- 239000004599 antimicrobial Substances 0.000 abstract description 2
- 230000003389 potentiating effect Effects 0.000 abstract description 2
- 125000000217 alkyl group Chemical group 0.000 description 360
- 239000001257 hydrogen Substances 0.000 description 230
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 211
- 125000000547 substituted alkyl group Chemical group 0.000 description 171
- 125000004414 alkyl thio group Chemical group 0.000 description 160
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 158
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 144
- 125000000753 cycloalkyl group Chemical group 0.000 description 122
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 109
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 98
- 239000000047 product Substances 0.000 description 90
- 239000000543 intermediate Substances 0.000 description 82
- 125000003342 alkenyl group Chemical group 0.000 description 81
- 239000000203 mixture Substances 0.000 description 78
- 125000001072 heteroaryl group Chemical class 0.000 description 76
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 73
- 125000000623 heterocyclic group Chemical class 0.000 description 71
- 238000006243 chemical reaction Methods 0.000 description 68
- 229910052760 oxygen Inorganic materials 0.000 description 67
- 239000001301 oxygen Substances 0.000 description 67
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 66
- 125000005017 substituted alkenyl group Chemical group 0.000 description 66
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 62
- 150000002926 oxygen Chemical class 0.000 description 60
- 150000002367 halogens Chemical class 0.000 description 55
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 53
- 125000003118 aryl group Chemical class 0.000 description 51
- 239000003153 chemical reaction reagent Substances 0.000 description 49
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 49
- 125000003545 alkoxy group Chemical group 0.000 description 46
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 44
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 43
- 239000003960 organic solvent Substances 0.000 description 42
- 125000003107 substituted aryl group Chemical class 0.000 description 42
- 125000001153 fluoro group Chemical group F* 0.000 description 40
- 125000005415 substituted alkoxy group Chemical group 0.000 description 39
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 38
- 229910052757 nitrogen Inorganic materials 0.000 description 38
- 239000011541 reaction mixture Substances 0.000 description 36
- 229910001868 water Inorganic materials 0.000 description 36
- 241000194032 Enterococcus faecalis Species 0.000 description 35
- 125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 description 35
- 229940032049 enterococcus faecalis Drugs 0.000 description 34
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 33
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 33
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 32
- 239000002585 base Substances 0.000 description 32
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 32
- 125000001997 phenyl group Chemical class [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 32
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 31
- 125000001424 substituent group Chemical group 0.000 description 31
- KOFBVFFPLADGGO-DUSUDKPKSA-N (3r,4s,5r,6r)-6-[(1r,2r)-1-amino-2-hydroxypropyl]oxane-2,3,4,5-tetrol Chemical compound C[C@@H](O)[C@@H](N)[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O KOFBVFFPLADGGO-DUSUDKPKSA-N 0.000 description 30
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 29
- 239000004480 active ingredient Substances 0.000 description 28
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 27
- 125000001118 alkylidene group Chemical group 0.000 description 27
- 125000004093 cyano group Chemical group *C#N 0.000 description 27
- 229910052799 carbon Inorganic materials 0.000 description 26
- 125000001309 chloro group Chemical group Cl* 0.000 description 26
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 24
- 150000002829 nitrogen Chemical class 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 235000019439 ethyl acetate Nutrition 0.000 description 23
- 239000002904 solvent Substances 0.000 description 23
- 241000606768 Haemophilus influenzae Species 0.000 description 22
- 229920006395 saturated elastomer Polymers 0.000 description 22
- 238000009472 formulation Methods 0.000 description 21
- 229940047650 haemophilus influenzae Drugs 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 20
- 229910020008 S(O) Inorganic materials 0.000 description 20
- 239000008194 pharmaceutical composition Substances 0.000 description 20
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 19
- 125000000304 alkynyl group Chemical group 0.000 description 19
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 18
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 18
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 18
- 150000007530 organic bases Chemical class 0.000 description 18
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 18
- 150000001412 amines Chemical class 0.000 description 17
- 241000124008 Mammalia Species 0.000 description 16
- 125000005083 alkoxyalkoxy group Chemical group 0.000 description 16
- 239000003054 catalyst Substances 0.000 description 16
- 208000015181 infectious disease Diseases 0.000 description 16
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 150000001409 amidines Chemical class 0.000 description 15
- 239000003242 anti bacterial agent Substances 0.000 description 15
- 125000004432 carbon atom Chemical group C* 0.000 description 15
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 150000002148 esters Chemical class 0.000 description 15
- 239000012634 fragment Substances 0.000 description 15
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 15
- 229920005989 resin Polymers 0.000 description 15
- 239000011347 resin Substances 0.000 description 15
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 14
- 239000012043 crude product Substances 0.000 description 14
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 14
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 14
- 229910052698 phosphorus Inorganic materials 0.000 description 14
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 14
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 13
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 13
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 13
- 238000005859 coupling reaction Methods 0.000 description 13
- 239000012038 nucleophile Substances 0.000 description 13
- 238000011282 treatment Methods 0.000 description 13
- 229910019142 PO4 Inorganic materials 0.000 description 12
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 12
- 239000002253 acid Substances 0.000 description 12
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 12
- 238000004587 chromatography analysis Methods 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 12
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 12
- 239000010452 phosphate Substances 0.000 description 12
- 239000011574 phosphorus Substances 0.000 description 12
- 125000006239 protecting group Chemical group 0.000 description 12
- 125000004426 substituted alkynyl group Chemical group 0.000 description 12
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 12
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 11
- 150000001336 alkenes Chemical class 0.000 description 11
- 229940024606 amino acid Drugs 0.000 description 11
- 235000001014 amino acid Nutrition 0.000 description 11
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 11
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 11
- 238000010511 deprotection reaction Methods 0.000 description 11
- 239000000546 pharmaceutical excipient Substances 0.000 description 11
- 239000003826 tablet Substances 0.000 description 11
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 238000005481 NMR spectroscopy Methods 0.000 description 10
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 10
- 229920002472 Starch Polymers 0.000 description 10
- 125000005163 aryl sulfanyl group Chemical group 0.000 description 10
- 125000001188 haloalkyl group Chemical group 0.000 description 10
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 10
- 150000004714 phosphonium salts Chemical class 0.000 description 10
- 239000003495 polar organic solvent Substances 0.000 description 10
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 10
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 description 10
- 229910052707 ruthenium Inorganic materials 0.000 description 10
- 235000019698 starch Nutrition 0.000 description 10
- ISXOBTBCNRIIQO-UHFFFAOYSA-N tetrahydrothiophene 1-oxide Chemical compound O=S1CCCC1 ISXOBTBCNRIIQO-UHFFFAOYSA-N 0.000 description 10
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 9
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 9
- 230000008878 coupling Effects 0.000 description 9
- 238000010168 coupling process Methods 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- OSFBJERFMQCEQY-UHFFFAOYSA-N propylidene Chemical group [CH]CC OSFBJERFMQCEQY-UHFFFAOYSA-N 0.000 description 9
- 239000008107 starch Substances 0.000 description 9
- 238000004809 thin layer chromatography Methods 0.000 description 9
- 238000005406 washing Methods 0.000 description 9
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 8
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- MEOZFUYXLCDYGA-UHFFFAOYSA-N azepane-1-carboxylic acid Chemical compound OC(=O)N1CCCCCC1 MEOZFUYXLCDYGA-UHFFFAOYSA-N 0.000 description 8
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 235000019359 magnesium stearate Nutrition 0.000 description 8
- 235000013930 proline Nutrition 0.000 description 8
- 238000006798 ring closing metathesis reaction Methods 0.000 description 8
- 125000006413 ring segment Chemical group 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 8
- 229910002027 silica gel Inorganic materials 0.000 description 8
- 239000000377 silicon dioxide Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 239000007858 starting material Substances 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 125000004001 thioalkyl group Chemical group 0.000 description 8
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 8
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 7
- 238000005160 1H NMR spectroscopy Methods 0.000 description 7
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 7
- 241000192125 Firmicutes Species 0.000 description 7
- 229910003827 NRaRb Inorganic materials 0.000 description 7
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 7
- 150000007513 acids Chemical class 0.000 description 7
- 238000007792 addition Methods 0.000 description 7
- 238000005804 alkylation reaction Methods 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000002552 dosage form Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000003937 drug carrier Substances 0.000 description 7
- 238000005984 hydrogenation reaction Methods 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 125000001979 organolithium group Chemical group 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 150000003222 pyridines Chemical class 0.000 description 7
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000010626 work up procedure Methods 0.000 description 7
- RUKVGXGTVPPWDD-UHFFFAOYSA-N 1,3-bis(2,4,6-trimethylphenyl)imidazolidine Chemical group CC1=CC(C)=CC(C)=C1N1CN(C=2C(=CC(C)=CC=2C)C)CC1 RUKVGXGTVPPWDD-UHFFFAOYSA-N 0.000 description 6
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 229910015900 BF3 Inorganic materials 0.000 description 6
- 239000004215 Carbon black (E152) Substances 0.000 description 6
- XCOBLONWWXQEBS-KPKJPENVSA-N N,O-bis(trimethylsilyl)trifluoroacetamide Chemical compound C[Si](C)(C)O\C(C(F)(F)F)=N\[Si](C)(C)C XCOBLONWWXQEBS-KPKJPENVSA-N 0.000 description 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 6
- 150000001299 aldehydes Chemical class 0.000 description 6
- 239000003513 alkali Substances 0.000 description 6
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 6
- 239000006184 cosolvent Substances 0.000 description 6
- 125000003963 dichloro group Chemical group Cl* 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 229930195733 hydrocarbon Natural products 0.000 description 6
- 150000002576 ketones Chemical class 0.000 description 6
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 6
- LSEFCHWGJNHZNT-UHFFFAOYSA-M methyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C)C1=CC=CC=C1 LSEFCHWGJNHZNT-UHFFFAOYSA-M 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 229960002429 proline Drugs 0.000 description 6
- 229910052717 sulfur Inorganic materials 0.000 description 6
- 239000011593 sulfur Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- DNUTZBZXLPWRJG-UHFFFAOYSA-N 1-Piperidine carboxylic acid Chemical compound OC(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-N 0.000 description 5
- 101150041968 CDC13 gene Proteins 0.000 description 5
- 241000194031 Enterococcus faecium Species 0.000 description 5
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 239000002168 alkylating agent Substances 0.000 description 5
- 229940100198 alkylating agent Drugs 0.000 description 5
- 239000012298 atmosphere Substances 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 239000012267 brine Substances 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 125000004966 cyanoalkyl group Chemical group 0.000 description 5
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 5
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 5
- 229910052731 fluorine Inorganic materials 0.000 description 5
- 150000002222 fluorine compounds Chemical class 0.000 description 5
- 239000007903 gelatin capsule Substances 0.000 description 5
- RCBVKBFIWMOMHF-UHFFFAOYSA-L hydroxy-(hydroxy(dioxo)chromio)oxy-dioxochromium;pyridine Chemical compound C1=CC=NC=C1.C1=CC=NC=C1.O[Cr](=O)(=O)O[Cr](O)(=O)=O RCBVKBFIWMOMHF-UHFFFAOYSA-L 0.000 description 5
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 5
- 229940041028 lincosamides Drugs 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 5
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical class OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 5
- 125000005936 piperidyl group Chemical group 0.000 description 5
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 5
- 150000003148 prolines Chemical class 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 238000006722 reduction reaction Methods 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- 230000000707 stereoselective effect Effects 0.000 description 5
- 125000003396 thiol group Chemical group [H]S* 0.000 description 5
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 5
- JCZPMGDSEAFWDY-MGCNEYSASA-N (2r,3s,4s,5r)-2,3,4,5,6-pentahydroxyhexanamide Chemical class NC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO JCZPMGDSEAFWDY-MGCNEYSASA-N 0.000 description 4
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 4
- KLTVSWGXIAYTHO-UHFFFAOYSA-N 1-Octen-3-one Chemical compound CCCCCC(=O)C=C KLTVSWGXIAYTHO-UHFFFAOYSA-N 0.000 description 4
- OEBXWWBYZJNKRK-UHFFFAOYSA-N 1-methyl-2,3,4,6,7,8-hexahydropyrimido[1,2-a]pyrimidine Chemical compound C1CCN=C2N(C)CCCN21 OEBXWWBYZJNKRK-UHFFFAOYSA-N 0.000 description 4
- WXZKPUNMAAPMMS-UHFFFAOYSA-N 2,3,6,7-tetrahydro-1h-azepine-2-carboxylic acid Chemical class OC(=O)C1CC=CCCN1 WXZKPUNMAAPMMS-UHFFFAOYSA-N 0.000 description 4
- FYEFLEUMNQBKHG-UHFFFAOYSA-N 2-(1-amino-2-methylpropyl)-6-methylsulfanyloxane-3,4,5-triol Chemical compound CSC1OC(C(N)C(C)C)C(O)C(O)C1O FYEFLEUMNQBKHG-UHFFFAOYSA-N 0.000 description 4
- 125000004791 2-fluoroethoxy group Chemical group FCCO* 0.000 description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 4
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 238000006845 Michael addition reaction Methods 0.000 description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 4
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 4
- 241000588655 Moraxella catarrhalis Species 0.000 description 4
- LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 4
- 239000007832 Na2SO4 Substances 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 4
- 238000007239 Wittig reaction Methods 0.000 description 4
- 125000004423 acyloxy group Chemical group 0.000 description 4
- 230000029936 alkylation Effects 0.000 description 4
- 125000002947 alkylene group Chemical group 0.000 description 4
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 239000012230 colorless oil Substances 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 125000005842 heteroatom Chemical group 0.000 description 4
- 150000002430 hydrocarbons Chemical group 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 4
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 4
- 239000008108 microcrystalline cellulose Substances 0.000 description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 description 4
- 229910052750 molybdenum Inorganic materials 0.000 description 4
- 239000011733 molybdenum Substances 0.000 description 4
- 125000002950 monocyclic group Chemical group 0.000 description 4
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 239000011736 potassium bicarbonate Substances 0.000 description 4
- 235000015497 potassium bicarbonate Nutrition 0.000 description 4
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 4
- 229960003908 pseudoephedrine Drugs 0.000 description 4
- 229910052705 radium Inorganic materials 0.000 description 4
- 229910052701 rubidium Inorganic materials 0.000 description 4
- 229930195734 saturated hydrocarbon Natural products 0.000 description 4
- 238000010898 silica gel chromatography Methods 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 4
- ZRPFJAPZDXQHSM-UHFFFAOYSA-L 1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazole;dichloro-[(2-propan-2-yloxyphenyl)methylidene]ruthenium Chemical compound CC(C)OC1=CC=CC=C1C=[Ru](Cl)(Cl)=C1N(C=2C(=CC(C)=CC=2C)C)CCN1C1=C(C)C=C(C)C=C1C ZRPFJAPZDXQHSM-UHFFFAOYSA-L 0.000 description 3
- HNEGJTWNOOWEMH-UHFFFAOYSA-N 1-fluoropropane Chemical group [CH2]CCF HNEGJTWNOOWEMH-UHFFFAOYSA-N 0.000 description 3
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 3
- 125000000134 2-(methylsulfanyl)ethyl group Chemical group [H]C([H])([H])SC([H])([H])C([H])([H])[*] 0.000 description 3
- YSULOORXQBDPCU-UHFFFAOYSA-N 2-(trimethylazaniumyl)ethanehydrazonate;hydrochloride Chemical compound [Cl-].C[N+](C)(C)CC(=O)NN YSULOORXQBDPCU-UHFFFAOYSA-N 0.000 description 3
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 3
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 3
- DNSDOTXFVIOTHM-UHFFFAOYSA-N 4-(3-imidazol-1-ylpropyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCCN2C=NC=C2)C1 DNSDOTXFVIOTHM-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- 208000035143 Bacterial infection Diseases 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 3
- DCERHCFNWRGHLK-UHFFFAOYSA-N C[Si](C)C Chemical compound C[Si](C)C DCERHCFNWRGHLK-UHFFFAOYSA-N 0.000 description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 3
- 208000007190 Chlamydia Infections Diseases 0.000 description 3
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- 239000007821 HATU Substances 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 101100189356 Mus musculus Papolb gene Proteins 0.000 description 3
- 206010028470 Mycoplasma infections Diseases 0.000 description 3
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 3
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 3
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 3
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 238000006859 Swern oxidation reaction Methods 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 125000004442 acylamino group Chemical group 0.000 description 3
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 3
- 125000000746 allylic group Chemical group 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 208000022362 bacterial infectious disease Diseases 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- XSCHRSMBECNVNS-UHFFFAOYSA-N benzopyrazine Natural products N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 3
- 230000008499 blood brain barrier function Effects 0.000 description 3
- 210000001218 blood-brain barrier Anatomy 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 229920005549 butyl rubber Polymers 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 229920001429 chelating resin Polymers 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 229960002227 clindamycin Drugs 0.000 description 3
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 3
- 238000010549 co-Evaporation Methods 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 150000007529 inorganic bases Chemical class 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 150000003951 lactams Chemical class 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 3
- 239000003863 metallic catalyst Substances 0.000 description 3
- CIOSLAWOFPYTJD-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-propyl-1,2,3,6-tetrahydropyridine-2-carboxamide Chemical compound C1C(CCC)=CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 CIOSLAWOFPYTJD-UHFFFAOYSA-N 0.000 description 3
- SAVQQRYWWAGSQW-UHFFFAOYSA-N n-methyl-n-(trifluoro-$l^{4}-sulfanyl)methanamine Chemical compound CN(C)S(F)(F)F SAVQQRYWWAGSQW-UHFFFAOYSA-N 0.000 description 3
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 230000020477 pH reduction Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000011181 potassium carbonates Nutrition 0.000 description 3
- 150000003138 primary alcohols Chemical class 0.000 description 3
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 229940124530 sulfonamide Drugs 0.000 description 3
- 150000003456 sulfonamides Chemical class 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 238000010189 synthetic method Methods 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- CAODDCZFBZNYSO-BYPYZUCNSA-N (2s)-3-oxopyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@H]1NCCC1=O CAODDCZFBZNYSO-BYPYZUCNSA-N 0.000 description 2
- DJXNNVQNRNVONE-UHFFFAOYSA-N (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-[[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]carbamoyl]-5-propylazepane-1-carboxylate Chemical compound C1CC(CCC)CCC(C(=O)NC(C(C)Cl)C2C(C(O)C(O)C(SC)O2)O)N1C(=O)OCC=1OC(=O)OC=1C DJXNNVQNRNVONE-UHFFFAOYSA-N 0.000 description 2
- IADUEWIQBXOCDZ-VKHMYHEASA-N (S)-azetidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCN1 IADUEWIQBXOCDZ-VKHMYHEASA-N 0.000 description 2
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 2
- YXTGYVVINPIWMF-UHFFFAOYSA-N 1-(1h-imidazol-2-ylmethyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound C1C(CCCCC)CC(C(=O)NC(C(C)C)C2C(C(O)C(O)C(SC)O2)O)N1CC1=NC=CN1 YXTGYVVINPIWMF-UHFFFAOYSA-N 0.000 description 2
- MFRNJOFFXJVNGY-UHFFFAOYSA-N 1-(2-amino-2-oxoethyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound NC(=O)CN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 MFRNJOFFXJVNGY-UHFFFAOYSA-N 0.000 description 2
- HARUDSUZZMKALL-UHFFFAOYSA-N 1-(cyanomethyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound N#CCN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 HARUDSUZZMKALL-UHFFFAOYSA-N 0.000 description 2
- NNHYAHOTXLASEA-UHFFFAOYSA-N 1-(dimethoxymethyl)-4-methoxybenzene Chemical compound COC(OC)C1=CC=C(OC)C=C1 NNHYAHOTXLASEA-UHFFFAOYSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 2
- BERAAJKLZUCLOQ-UHFFFAOYSA-N 1-methanimidoyl-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound N=CN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 BERAAJKLZUCLOQ-UHFFFAOYSA-N 0.000 description 2
- HBEDSQVIWPRPAY-UHFFFAOYSA-N 2,3-dihydrobenzofuran Chemical compound C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- KWMBADTWRIGGGG-UHFFFAOYSA-N 2-diethoxyphosphorylacetonitrile Chemical compound CCOP(=O)(CC#N)OCC KWMBADTWRIGGGG-UHFFFAOYSA-N 0.000 description 2
- YEDUAINPPJYDJZ-UHFFFAOYSA-N 2-hydroxybenzothiazole Chemical compound C1=CC=C2SC(O)=NC2=C1 YEDUAINPPJYDJZ-UHFFFAOYSA-N 0.000 description 2
- APOYTRAZFJURPB-UHFFFAOYSA-N 2-methoxy-n-(2-methoxyethyl)-n-(trifluoro-$l^{4}-sulfanyl)ethanamine Chemical compound COCCN(S(F)(F)F)CCOC APOYTRAZFJURPB-UHFFFAOYSA-N 0.000 description 2
- WPHUUIODWRNJLO-UHFFFAOYSA-N 2-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=CC=C1S(Cl)(=O)=O WPHUUIODWRNJLO-UHFFFAOYSA-N 0.000 description 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- ORHUTNZUHATDOA-UHFFFAOYSA-N 4-(3-cyanopropyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCCC#N)C1 ORHUTNZUHATDOA-UHFFFAOYSA-N 0.000 description 2
- XIMHZYAPAGVPED-UHFFFAOYSA-N 4-(3-ethoxyiminopropyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound C1C(CCC=NOCC)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 XIMHZYAPAGVPED-UHFFFAOYSA-N 0.000 description 2
- YXHXKZBXKLKBML-UHFFFAOYSA-N 4-(3-ethylsulfanylpropyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound C1C(CCCSCC)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 YXHXKZBXKLKBML-UHFFFAOYSA-N 0.000 description 2
- DFFGSIHJPZINEB-UHFFFAOYSA-N 4-(3-methoxyiminopropyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound C1C(CCC=NOC)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 DFFGSIHJPZINEB-UHFFFAOYSA-N 0.000 description 2
- UUHWQBMPDDOBFD-UHFFFAOYSA-N 4-[(2,4-dichlorophenyl)methylsulfanyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCC(SCC=2C(=CC(Cl)=CC=2)Cl)C1 UUHWQBMPDDOBFD-UHFFFAOYSA-N 0.000 description 2
- VMVKTZMYJAAJIR-UHFFFAOYSA-N 4-[2-(1,3-dithiolan-2-yl)ethyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCC2SCCS2)C1 VMVKTZMYJAAJIR-UHFFFAOYSA-N 0.000 description 2
- OZBVXYHTCGJFOZ-UHFFFAOYSA-N 4-[2-(4-methyl-1,3-thiazol-2-yl)ethyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCC=2SC=C(C)N=2)C1 OZBVXYHTCGJFOZ-UHFFFAOYSA-N 0.000 description 2
- SQKDXZQUEXTRJB-UHFFFAOYSA-N 4-[3-(difluoromethylsulfanyl)propyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCCSC(F)F)C1 SQKDXZQUEXTRJB-UHFFFAOYSA-N 0.000 description 2
- HDINUXUNJMXPJX-UHFFFAOYSA-N 4-[3-(furan-2-ylmethylsulfanyl)propyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCCSCC=2OC=CC=2)C1 HDINUXUNJMXPJX-UHFFFAOYSA-N 0.000 description 2
- QSWMXBBKOQVGOX-UHFFFAOYSA-N 4-fluoro-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-propylpyrrolidine-2-carboxamide Chemical compound C1C(CCC)(F)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 QSWMXBBKOQVGOX-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- 241000606125 Bacteroides Species 0.000 description 2
- 241000606123 Bacteroides thetaiotaomicron Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 241000193163 Clostridioides difficile Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- YIIMEMSDCNDGTB-UHFFFAOYSA-N Dimethylcarbamoyl chloride Chemical compound CN(C)C(Cl)=O YIIMEMSDCNDGTB-UHFFFAOYSA-N 0.000 description 2
- 241000194033 Enterococcus Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 239000007818 Grignard reagent Substances 0.000 description 2
- 101000988651 Homo sapiens Humanin-like 1 Proteins 0.000 description 2
- 101001081172 Homo sapiens Humanin-like 11 Proteins 0.000 description 2
- 102100027736 Humanin-like 11 Human genes 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- 229910013470 LiC1 Inorganic materials 0.000 description 2
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 101100272976 Panax ginseng CYP716A53v2 gene Proteins 0.000 description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000007295 Wittig olefination reaction Methods 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 238000005865 alkene metathesis reaction Methods 0.000 description 2
- 150000001347 alkyl bromides Chemical class 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 125000005097 aminocarbonylalkyl group Chemical group 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000008365 aqueous carrier Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- OPFURXRZISKMJV-UHFFFAOYSA-N azepan-1-ium-2-carboxylate Chemical class OC(=O)C1CCCCCN1 OPFURXRZISKMJV-UHFFFAOYSA-N 0.000 description 2
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 2
- MJSHDCCLFGOEIK-UHFFFAOYSA-N benzyl (2,5-dioxopyrrolidin-1-yl) carbonate Chemical compound O=C1CCC(=O)N1OC(=O)OCC1=CC=CC=C1 MJSHDCCLFGOEIK-UHFFFAOYSA-N 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- FCDPQMAOJARMTG-UHFFFAOYSA-M benzylidene-[1,3-bis(2,4,6-trimethylphenyl)imidazolidin-2-ylidene]-dichlororuthenium;tricyclohexylphosphanium Chemical compound C1CCCCC1[PH+](C1CCCCC1)C1CCCCC1.CC1=CC(C)=CC(C)=C1N(CCN1C=2C(=CC(C)=CC=2C)C)C1=[Ru](Cl)(Cl)=CC1=CC=CC=C1 FCDPQMAOJARMTG-UHFFFAOYSA-M 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 150000007942 carboxylates Chemical class 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 description 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000000132 electrospray ionisation Methods 0.000 description 2
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
- 239000008387 emulsifying waxe Substances 0.000 description 2
- 239000012055 enteric layer Substances 0.000 description 2
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical class O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 2
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 2
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 244000000058 gram-negative pathogen Species 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000002140 halogenating effect Effects 0.000 description 2
- 150000002374 hemiaminals Chemical class 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- COQRGFWWJBEXRC-UHFFFAOYSA-N hydron;methyl 2-aminoacetate;chloride Chemical compound Cl.COC(=O)CN COQRGFWWJBEXRC-UHFFFAOYSA-N 0.000 description 2
- XNXVOSBNFZWHBV-UHFFFAOYSA-N hydron;o-methylhydroxylamine;chloride Chemical compound Cl.CON XNXVOSBNFZWHBV-UHFFFAOYSA-N 0.000 description 2
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
- 150000002466 imines Chemical class 0.000 description 2
- LPAGFVYQRIESJQ-UHFFFAOYSA-N indoline Chemical compound C1=CC=C2NCCC2=C1 LPAGFVYQRIESJQ-UHFFFAOYSA-N 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 229960005287 lincomycin Drugs 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- RMGJCSHZTFKPNO-UHFFFAOYSA-M magnesium;ethene;bromide Chemical compound [Mg+2].[Br-].[CH-]=C RMGJCSHZTFKPNO-UHFFFAOYSA-M 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- JHQZRHILTYGZQL-YFKPBYRVSA-N methyl (2s)-2-aminopent-4-enoate Chemical compound COC(=O)[C@@H](N)CC=C JHQZRHILTYGZQL-YFKPBYRVSA-N 0.000 description 2
- VMVNZNXAVJHNDJ-UHFFFAOYSA-N methyl 2,2,2-trifluoroacetate Chemical compound COC(=O)C(F)(F)F VMVNZNXAVJHNDJ-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical group OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
- KYGJZIHIPWUWKP-UHFFFAOYSA-N n-[(4-chlorophenyl)-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)methyl]-1-methyl-4-propylpyrrolidine-2-carboxamide Chemical compound CN1CC(CCC)CC1C(=O)NC(C=1C=CC(Cl)=CC=1)C1C(O)C(O)C(O)C(SC)O1 KYGJZIHIPWUWKP-UHFFFAOYSA-N 0.000 description 2
- JEWPVRAVLNZTFI-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-[3-(difluoromethylsulfanyl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCCC(CCCSC(F)F)C1 JEWPVRAVLNZTFI-UHFFFAOYSA-N 0.000 description 2
- LOTXOLDKOMAKAY-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-ethylsulfanylpyrrolidine-2-carboxamide Chemical compound C1C(SCC)CNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 LOTXOLDKOMAKAY-UHFFFAOYSA-N 0.000 description 2
- MWFXOTFLZLDBEM-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-fluoro-4-propylpiperidine-2-carboxamide Chemical compound C1C(CCC)(F)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 MWFXOTFLZLDBEM-UHFFFAOYSA-N 0.000 description 2
- LFAIRROQEQNGKW-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-5-(cyclopropylmethyl)azepane-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCCC(CC2CC2)CC1 LFAIRROQEQNGKW-UHFFFAOYSA-N 0.000 description 2
- JVISVMUDZYPDBM-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-5-ethylazepane-2-carboxamide Chemical compound C1CC(CC)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 JVISVMUDZYPDBM-UHFFFAOYSA-N 0.000 description 2
- KWAVCLCNECFROS-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-5-propylazepane-2-carboxamide Chemical compound C1CC(CCC)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 KWAVCLCNECFROS-UHFFFAOYSA-N 0.000 description 2
- JYWRNFNQNIZOEQ-UHFFFAOYSA-N n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(thiophen-2-ylmethylsulfanyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCC=2SC=CC=2)C1 JYWRNFNQNIZOEQ-UHFFFAOYSA-N 0.000 description 2
- WMLLIPGOPKGHDP-UHFFFAOYSA-N n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-[(4-methylphenyl)methylsulfanyl]pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCC=2C=CC(C)=CC=2)C1 WMLLIPGOPKGHDP-UHFFFAOYSA-N 0.000 description 2
- BQABFQXRHPUTGW-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(3-pyridin-4-ylpropyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCC(CCCC=2C=CN=CC=2)C1 BQABFQXRHPUTGW-UHFFFAOYSA-N 0.000 description 2
- OLRKOHTWARFZBA-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(3-thiophen-2-ylsulfanylpropyl)piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCCSC=2SC=CC=2)C1 OLRKOHTWARFZBA-UHFFFAOYSA-N 0.000 description 2
- UXIKMADAIRHBGI-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-propyl-1,2,3,6-tetrahydropyridine-2-carboxamide Chemical compound C1C(CCC)=CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 UXIKMADAIRHBGI-UHFFFAOYSA-N 0.000 description 2
- HETSCOAYMHOHEH-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-propylidenepiperidine-2-carboxamide Chemical compound C1C(=CCC)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 HETSCOAYMHOHEH-UHFFFAOYSA-N 0.000 description 2
- JKHWQWJALQYFJI-UHFFFAOYSA-N n-[cyclopropyl-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)methyl]-4-propylpiperidine-2-carboxamide Chemical compound C1C(CCC)CCNC1C(=O)NC(C1C(C(O)C(O)C(SC)O1)O)C1CC1 JKHWQWJALQYFJI-UHFFFAOYSA-N 0.000 description 2
- GSFQJVMELLKQFD-UHFFFAOYSA-N n-[cyclopropyl-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)methyl]-5-propylazepane-2-carboxamide Chemical compound C1CC(CCC)CCNC1C(=O)NC(C1C(C(O)C(O)C(SC)O1)O)C1CC1 GSFQJVMELLKQFD-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000006574 non-aromatic ring group Chemical group 0.000 description 2
- AEKHNNJSMVVESS-UHFFFAOYSA-N o-trimethylsilylhydroxylamine Chemical compound C[Si](C)(C)ON AEKHNNJSMVVESS-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical group CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Chemical group CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229940037201 oris Drugs 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 150000002923 oximes Chemical group 0.000 description 2
- 238000005949 ozonolysis reaction Methods 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- 239000008177 pharmaceutical agent Substances 0.000 description 2
- 229940124531 pharmaceutical excipient Drugs 0.000 description 2
- RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 2
- KOGLZVRPQJRCHE-UHFFFAOYSA-N phenyl 2-[[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]carbamoyl]-4-propylpiperidine-1-carboxylate Chemical compound C1C(CCC)CCN(C(=O)OC=2C=CC=CC=2)C1C(=O)NC(C(C)C)C1OC(SC)C(O)C(O)C1O KOGLZVRPQJRCHE-UHFFFAOYSA-N 0.000 description 2
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical class O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical class O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 239000008247 solid mixture Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000008117 stearic acid Chemical group 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- XJPKDRJZNZMJQM-UHFFFAOYSA-N tetrakis(prop-2-enyl)stannane Chemical compound C=CC[Sn](CC=C)(CC=C)CC=C XJPKDRJZNZMJQM-UHFFFAOYSA-N 0.000 description 2
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 238000005891 transamination reaction Methods 0.000 description 2
- HYWCXWRMUZYRPH-UHFFFAOYSA-N trimethyl(prop-2-enyl)silane Chemical compound C[Si](C)(C)CC=C HYWCXWRMUZYRPH-UHFFFAOYSA-N 0.000 description 2
- LEIMLDGFXIOXMT-UHFFFAOYSA-N trimethylsilyl cyanide Chemical compound C[Si](C)(C)C#N LEIMLDGFXIOXMT-UHFFFAOYSA-N 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- XXBNLUKLCXTTPH-MGCNEYSASA-N (2r,3s,4s,5r)-2,3,4,5,6-pentahydroxyhexanoyl chloride Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C(Cl)=O XXBNLUKLCXTTPH-MGCNEYSASA-N 0.000 description 1
- TWYYFYNJOJGNFP-CUXYNZQBSA-N (2s,4r,5s,6s)-2-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-2-carbamoyl-4-[[(e,4s,6s)-4,6-dimethyloct-2-enoyl]oxymethyl]-5-hydroxy-1,3-dioxane-4,5,6-tricarboxylic acid Chemical compound O1[C@H](C(O)=O)[C@](C(O)=O)(O)[C@](COC(=O)/C=C/[C@@H](C)C[C@@H](C)CC)(C(O)=O)O[C@]1(C(N)=O)CCC(=C)[C@@H](OC(C)=O)[C@H](C)CC1=CC=CC=C1 TWYYFYNJOJGNFP-CUXYNZQBSA-N 0.000 description 1
- BIKDOQRECXQNQR-UHFFFAOYSA-N (4-chlorophenyl)methylphosphanium;chloride Chemical compound [Cl-].[PH3+]CC1=CC=C(Cl)C=C1 BIKDOQRECXQNQR-UHFFFAOYSA-N 0.000 description 1
- VUDZSIYXZUYWSC-DBRKOABJSA-N (4r)-1-[(2r,4r,5r)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one Chemical compound FC1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N[C@H](O)CC1 VUDZSIYXZUYWSC-DBRKOABJSA-N 0.000 description 1
- MZGIKNSLLFWGKL-UHFFFAOYSA-N (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (4-nitrophenyl) carbonate Chemical compound O1C(=O)OC(COC(=O)OC=2C=CC(=CC=2)[N+]([O-])=O)=C1C MZGIKNSLLFWGKL-UHFFFAOYSA-N 0.000 description 1
- YWSIYGYYHNXBAV-UHFFFAOYSA-N (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-[[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]carbamoyl]-4-fluoro-4-propylpiperidine-1-carboxylate Chemical compound C1C(CCC)(F)CCN(C(=O)OCC2=C(OC(=O)O2)C)C1C(=O)NC(C(C)Cl)C1OC(SC)C(O)C(O)C1O YWSIYGYYHNXBAV-UHFFFAOYSA-N 0.000 description 1
- LBLXDAMQMROUNM-UHFFFAOYSA-N (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-[[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]carbamoyl]-5-(cyclopropylmethyl)azepane-1-carboxylate Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1N(C(=O)OCC2=C(OC(=O)O2)C)CCC(CC2CC2)CC1 LBLXDAMQMROUNM-UHFFFAOYSA-N 0.000 description 1
- BYSAADGMIYMMHI-UHFFFAOYSA-N (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-[[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]carbamoyl]-5-fluoro-5-propylazepane-1-carboxylate Chemical compound C1CC(CCC)(F)CCC(C(=O)NC(C(C)Cl)C2C(C(O)C(O)C(SC)O2)O)N1C(=O)OCC=1OC(=O)OC=1C BYSAADGMIYMMHI-UHFFFAOYSA-N 0.000 description 1
- ZLYNPMCTYTWOKI-UHFFFAOYSA-N (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-[[2-methyl-1-(3,4,5-trihydroxy-6-propyloxan-2-yl)propyl]carbamoyl]-4-pentylpyrrolidine-1-carboxylate Chemical compound C1C(CCCCC)CC(C(=O)NC(C(C)C)C2C(C(O)C(O)C(CCC)O2)O)N1C(=O)OCC=1OC(=O)OC=1C ZLYNPMCTYTWOKI-UHFFFAOYSA-N 0.000 description 1
- DXLZIQZZYZSKEP-UHFFFAOYSA-N (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-[[2-methyl-1-(3,4,5-trihydroxy-6-propyloxan-2-yl)propyl]carbamoyl]-4-propylpyrrolidine-1-carboxylate Chemical compound C1C(CCC)CC(C(=O)NC(C(C)C)C2C(C(O)C(O)C(CCC)O2)O)N1C(=O)OCC=1OC(=O)OC=1C DXLZIQZZYZSKEP-UHFFFAOYSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FTBPZRNURKMEFD-ARJAWSKDSA-N (z)-1-bromopent-2-ene Chemical compound CC\C=C/CBr FTBPZRNURKMEFD-ARJAWSKDSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- FTNJQNQLEGKTGD-UHFFFAOYSA-N 1,3-benzodioxole Chemical compound C1=CC=C2OCOC2=C1 FTNJQNQLEGKTGD-UHFFFAOYSA-N 0.000 description 1
- OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 description 1
- CVIFYQUYQFXVDZ-UHFFFAOYSA-N 1-(2-aminoethyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound NCCN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 CVIFYQUYQFXVDZ-UHFFFAOYSA-N 0.000 description 1
- KAJCUQFVHXVSBW-UHFFFAOYSA-N 1-(2-formamidoethyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound O=CNCCN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 KAJCUQFVHXVSBW-UHFFFAOYSA-N 0.000 description 1
- WGSLYMHXZQYHCE-UHFFFAOYSA-N 1-(2-hydroxyethyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-propyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound OCCN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CCC)O1 WGSLYMHXZQYHCE-UHFFFAOYSA-N 0.000 description 1
- UMLHDABYMANNEV-UHFFFAOYSA-N 1-(2-methoxyethyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound COCCN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 UMLHDABYMANNEV-UHFFFAOYSA-N 0.000 description 1
- WUYRBSXENHJOMH-UHFFFAOYSA-N 1-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-propylpiperidine-2-carboxamide Chemical compound O1C(SC)C(O)C(O)C(O)C1C(C(C)C)NC(=O)C1CC(CCC)CCN1CC=1OC(=O)OC=1C WUYRBSXENHJOMH-UHFFFAOYSA-N 0.000 description 1
- UGGZVDLWLHNKNW-UHFFFAOYSA-N 1-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-propyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound C1C(CCCCC)CC(C(=O)NC(C(C)C)C2C(C(O)C(O)C(CCC)O2)O)N1CC=1OC(=O)OC=1C UGGZVDLWLHNKNW-UHFFFAOYSA-N 0.000 description 1
- BUYZXQSVHVDPON-UHFFFAOYSA-N 1-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-propyloxan-2-yl)propyl]-4-propylpyrrolidine-2-carboxamide Chemical compound C1C(CCC)CC(C(=O)NC(C(C)C)C2C(C(O)C(O)C(CCC)O2)O)N1CC=1OC(=O)OC=1C BUYZXQSVHVDPON-UHFFFAOYSA-N 0.000 description 1
- RJXIDLJYORRWLJ-UHFFFAOYSA-N 1-[2-(methylamino)-2-oxoethyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound CNC(=O)CN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 RJXIDLJYORRWLJ-UHFFFAOYSA-N 0.000 description 1
- LOYZVRIHVZEDMW-UHFFFAOYSA-N 1-bromo-3-methylbut-2-ene Chemical compound CC(C)=CCBr LOYZVRIHVZEDMW-UHFFFAOYSA-N 0.000 description 1
- MICMHFIQSAMEJG-UHFFFAOYSA-N 1-bromopyrrolidine-2,5-dione Chemical compound BrN1C(=O)CCC1=O.BrN1C(=O)CCC1=O MICMHFIQSAMEJG-UHFFFAOYSA-N 0.000 description 1
- 125000001478 1-chloroethyl group Chemical group [H]C([H])([H])C([H])(Cl)* 0.000 description 1
- 125000004776 1-fluoroethyl group Chemical group [H]C([H])([H])C([H])(F)* 0.000 description 1
- IWBQFTFQDUGRJZ-UHFFFAOYSA-N 1-methyl-4-propyl-n-[1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)but-3-enyl]pyrrolidine-2-carboxamide Chemical compound CN1CC(CCC)CC1C(=O)NC(CC=C)C1C(O)C(O)C(O)C(SC)O1 IWBQFTFQDUGRJZ-UHFFFAOYSA-N 0.000 description 1
- PVKIOTZDEBXJRH-UHFFFAOYSA-N 1-methyl-4-propyl-n-[1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)butyl]pyrrolidine-2-carboxamide Chemical compound O1C(SC)C(O)C(O)C(O)C1C(CCC)NC(=O)C1CC(CCC)CN1C PVKIOTZDEBXJRH-UHFFFAOYSA-N 0.000 description 1
- STQZOLPJNZICOG-UHFFFAOYSA-N 1-methyl-n-[phenyl-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)methyl]-4-propylpyrrolidine-2-carboxamide Chemical compound CN1CC(CCC)CC1C(=O)NC(C=1C=CC=CC=1)C1C(O)C(O)C(O)C(SC)O1 STQZOLPJNZICOG-UHFFFAOYSA-N 0.000 description 1
- AMMPLVWPWSYRDR-UHFFFAOYSA-N 1-methylbicyclo[2.2.2]oct-2-ene-4-carboxylic acid Chemical compound C1CC2(C(O)=O)CCC1(C)C=C2 AMMPLVWPWSYRDR-UHFFFAOYSA-N 0.000 description 1
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
- TZMSYXZUNZXBOL-UHFFFAOYSA-N 10H-phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- DTRBIIDYMYVRNE-UHFFFAOYSA-N 1h-azepine-2-carboxylic acid Chemical class OC(=O)C1=CC=CC=CN1 DTRBIIDYMYVRNE-UHFFFAOYSA-N 0.000 description 1
- NRKYWOKHZRQRJR-UHFFFAOYSA-N 2,2,2-trifluoroacetamide Chemical compound NC(=O)C(F)(F)F NRKYWOKHZRQRJR-UHFFFAOYSA-N 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- RJCHLKZWCLIACQ-UHFFFAOYSA-N 2,5-dihydro-1-benzoxepine Chemical compound C1C=CCOC2=CC=CC=C21 RJCHLKZWCLIACQ-UHFFFAOYSA-N 0.000 description 1
- TVVQUVMUAMNLLX-UHFFFAOYSA-N 2-(1-amino-2-chloropropyl)-6-methylsulfanyloxane-3,4,5-triol Chemical compound CSC1OC(C(N)C(C)Cl)C(O)C(O)C1O TVVQUVMUAMNLLX-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
- AUVALWUPUHHNQV-UHFFFAOYSA-N 2-hydroxy-3-propylbenzoic acid Chemical class CCCC1=CC=CC(C(O)=O)=C1O AUVALWUPUHHNQV-UHFFFAOYSA-N 0.000 description 1
- UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical group C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 description 1
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- VLRSADZEDXVUPG-UHFFFAOYSA-N 2-naphthalen-1-ylpyridine Chemical compound N1=CC=CC=C1C1=CC=CC2=CC=CC=C12 VLRSADZEDXVUPG-UHFFFAOYSA-N 0.000 description 1
- VHMICKWLTGFITH-UHFFFAOYSA-N 2H-isoindole Chemical compound C1=CC=CC2=CNC=C21 VHMICKWLTGFITH-UHFFFAOYSA-N 0.000 description 1
- XLZYKTYMLBOINK-UHFFFAOYSA-N 3-(4-hydroxybenzoyl)benzoic acid Chemical compound OC(=O)C1=CC=CC(C(=O)C=2C=CC(O)=CC=2)=C1 XLZYKTYMLBOINK-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- WXXSLCUWLQKWJG-UHFFFAOYSA-N 3-butyl-n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-1-(2-hydroxyethyl)azetidine-2-carboxamide Chemical compound CCCCC1CN(CCO)C1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 WXXSLCUWLQKWJG-UHFFFAOYSA-N 0.000 description 1
- FSNHRYGTEANCBQ-UHFFFAOYSA-N 3-butyl-n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-1-methylazetidine-2-carboxamide Chemical compound CCCCC1CN(C)C1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 FSNHRYGTEANCBQ-UHFFFAOYSA-N 0.000 description 1
- ZTEWLMFCJAVOKT-UHFFFAOYSA-N 3-butyl-n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]azetidine-2-carboxamide Chemical compound CCCCC1CNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 ZTEWLMFCJAVOKT-UHFFFAOYSA-N 0.000 description 1
- ZRPLANDPDWYOMZ-UHFFFAOYSA-N 3-cyclopentylpropionic acid Chemical compound OC(=O)CCC1CCCC1 ZRPLANDPDWYOMZ-UHFFFAOYSA-N 0.000 description 1
- CBKDCOKSXCTDAA-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1-benzothiophene Chemical compound C1CCCC2=C1C=CS2 CBKDCOKSXCTDAA-UHFFFAOYSA-N 0.000 description 1
- XMDYPUOLCNHCRW-UHFFFAOYSA-N 4-(2-cyclobutylideneethyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCC(CC=C2CCC2)C1 XMDYPUOLCNHCRW-UHFFFAOYSA-N 0.000 description 1
- IPSSNWBTNLRVJF-UHFFFAOYSA-N 4-(3-cyclohexyloxypropyl)-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCCOC2CCCCC2)C1 IPSSNWBTNLRVJF-UHFFFAOYSA-N 0.000 description 1
- XFNUUYSUWJWLNT-UHFFFAOYSA-N 4-(4-fluorophenyl)sulfanyl-n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SC=2C=CC(F)=CC=2)C1 XFNUUYSUWJWLNT-UHFFFAOYSA-N 0.000 description 1
- GWFALVUXAGYMHR-UHFFFAOYSA-N 4-(bromomethyl)-5-methyl-1,3-dioxol-2-one Chemical compound CC=1OC(=O)OC=1CBr GWFALVUXAGYMHR-UHFFFAOYSA-N 0.000 description 1
- GKALPOLBBGCSPP-UHFFFAOYSA-N 4-(pyrazin-2-ylmethylsulfanyl)pyrrolidine-2-carboxylic acid Chemical compound C1NC(C(=O)O)CC1SCC1=CN=CC=N1 GKALPOLBBGCSPP-UHFFFAOYSA-N 0.000 description 1
- SZTWHSOWUZVABA-UHFFFAOYSA-N 4-[(2,4-dichlorophenyl)methylsulfanyl]-n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCC=2C(=CC(Cl)=CC=2)Cl)C1 SZTWHSOWUZVABA-UHFFFAOYSA-N 0.000 description 1
- LENXSCSKTOFZOG-UHFFFAOYSA-N 4-[(4-fluorophenyl)methylsulfanyl]-n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCC=2C=CC(F)=CC=2)C1 LENXSCSKTOFZOG-UHFFFAOYSA-N 0.000 description 1
- CVROZZFVFAXTKC-UHFFFAOYSA-N 4-[2-(4-ethyl-1,3-thiazol-2-yl)ethyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound CCC1=CSC(CCC2CC(NCC2)C(=O)NC(C(C)C)C2C(C(O)C(O)C(SC)O2)O)=N1 CVROZZFVFAXTKC-UHFFFAOYSA-N 0.000 description 1
- LDSNHMNMLIXWII-UHFFFAOYSA-N 4-[2-(5-ethyl-1,2-oxazol-3-yl)ethyl]-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]piperidine-2-carboxamide Chemical compound O1C(CC)=CC(CCC2CC(NCC2)C(=O)NC(C(C)C)C2C(C(O)C(O)C(SC)O2)O)=N1 LDSNHMNMLIXWII-UHFFFAOYSA-N 0.000 description 1
- WPFAQYKHMZIFSG-UHFFFAOYSA-N 4-azido-n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(N=[N+]=[N-])C1 WPFAQYKHMZIFSG-UHFFFAOYSA-N 0.000 description 1
- FWKVABSODRWXDO-UHFFFAOYSA-N 4-butyl-1-methyl-n-[2-methyl-1-(3,4,5-trihydroxy-6-propyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound CN1CC(CCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CCC)O1 FWKVABSODRWXDO-UHFFFAOYSA-N 0.000 description 1
- LQMYXRHMFPOZLD-UHFFFAOYSA-N 4-butyl-n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-1,2,3,6-tetrahydropyridine-2-carboxamide Chemical compound C1C(CCCC)=CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 LQMYXRHMFPOZLD-UHFFFAOYSA-N 0.000 description 1
- KKPMDCGTGDKTLH-UHFFFAOYSA-N 4-butyl-n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-fluoropiperidine-2-carboxamide Chemical compound C1C(CCCC)(F)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 KKPMDCGTGDKTLH-UHFFFAOYSA-N 0.000 description 1
- HOMBFSNQMLWBHF-UHFFFAOYSA-N 4-butyl-n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-fluoropyrrolidine-2-carboxamide Chemical compound C1C(CCCC)(F)CNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 HOMBFSNQMLWBHF-UHFFFAOYSA-N 0.000 description 1
- OOBDYTCCCXGKCK-UHFFFAOYSA-N 4-butyl-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-1,2,3,6-tetrahydropyridine-2-carboxamide Chemical compound C1C(CCCC)=CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 OOBDYTCCCXGKCK-UHFFFAOYSA-N 0.000 description 1
- RIARHRRVRFDSBD-UHFFFAOYSA-N 4-butylsulfanyl-n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound C1C(SCCCC)CNC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 RIARHRRVRFDSBD-UHFFFAOYSA-N 0.000 description 1
- ZLAXTLUWJXUNMJ-UHFFFAOYSA-N 4-butylsulfanyl-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound C1C(SCCCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 ZLAXTLUWJXUNMJ-UHFFFAOYSA-N 0.000 description 1
- RJWBTWIBUIGANW-UHFFFAOYSA-N 4-chlorobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(Cl)C=C1 RJWBTWIBUIGANW-UHFFFAOYSA-N 0.000 description 1
- RIBVZRFRMBNDEX-UHFFFAOYSA-N 4-ethylsulfanyl-n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]pyrrolidine-2-carboxamide Chemical compound C1C(SCC)CNC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 RIBVZRFRMBNDEX-UHFFFAOYSA-N 0.000 description 1
- JBJQSHTWWODLSA-UHFFFAOYSA-N 4-fluoro-1-(2-hydroxyethyl)-4-propylpyrrolidine-2-carboxylic acid Chemical compound CCCC1(F)CC(C(O)=O)N(CCO)C1 JBJQSHTWWODLSA-UHFFFAOYSA-N 0.000 description 1
- KJQAZPSDPJLGHW-UHFFFAOYSA-N 4-fluoro-n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-propylpyrrolidine-2-carboxamide Chemical compound C1C(CCC)(F)CNC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 KJQAZPSDPJLGHW-UHFFFAOYSA-N 0.000 description 1
- MKTSNRNWQWWNBS-UHFFFAOYSA-N 4-fluoro-n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-propylpiperidine-2-carboxamide Chemical compound C1C(CCC)(F)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 MKTSNRNWQWWNBS-UHFFFAOYSA-N 0.000 description 1
- HFXAFXVXPMUQCQ-BYPYZUCNSA-N 4-oxo-L-proline Chemical compound OC(=O)[C@@H]1CC(=O)CN1 HFXAFXVXPMUQCQ-BYPYZUCNSA-N 0.000 description 1
- LAGFMWUJRVNCOD-UHFFFAOYSA-N 4-propyl-n-[1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)but-3-enyl]piperidine-2-carboxamide Chemical compound C1C(CCC)CCNC1C(=O)NC(CC=C)C1C(O)C(O)C(O)C(SC)O1 LAGFMWUJRVNCOD-UHFFFAOYSA-N 0.000 description 1
- JZQCGLIVUMEIFQ-UHFFFAOYSA-N 4-propyl-n-[1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)butyl]piperidine-2-carboxamide Chemical compound O1C(SC)C(O)C(O)C(O)C1C(CCC)NC(=O)C1CC(CCC)CCN1 JZQCGLIVUMEIFQ-UHFFFAOYSA-N 0.000 description 1
- GDRVFDDBLLKWRI-UHFFFAOYSA-N 4H-quinolizine Chemical compound C1=CC=CN2CC=CC=C21 GDRVFDDBLLKWRI-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- ILBCIHAFSZLSKP-UHFFFAOYSA-N 5-propyl-n-[1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)butyl]azepane-2-carboxamide Chemical compound O1C(SC)C(O)C(O)C(O)C1C(CCC)NC(=O)C1CCC(CCC)CCN1 ILBCIHAFSZLSKP-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 240000004178 Anthoxanthum odoratum Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- VFHPHBGZIZTJDN-UHFFFAOYSA-N C1=CC=C2C3=C(CC(C)(C)CC4=O)C4=CN=C3C=CC2=C1 Chemical compound C1=CC=C2C3=C(CC(C)(C)CC4=O)C4=CN=C3C=CC2=C1 VFHPHBGZIZTJDN-UHFFFAOYSA-N 0.000 description 1
- POIVICPLCYEACF-UHFFFAOYSA-N C1CC1C=C=CC1CCCCC1 Chemical group C1CC1C=C=CC1CCCCC1 POIVICPLCYEACF-UHFFFAOYSA-N 0.000 description 1
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical group CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
- 241001432959 Chernes Species 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Chemical group OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- 238000006236 Dondoni homologation reaction Methods 0.000 description 1
- GYCKQBWUSACYIF-UHFFFAOYSA-N Ethyl salicylate Chemical compound CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Chemical group OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 238000007101 Grubbs Olefin metathesis reaction Methods 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229910004373 HOAc Inorganic materials 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 241001539176 Hime Species 0.000 description 1
- 238000006130 Horner-Wadsworth-Emmons olefination reaction Methods 0.000 description 1
- 238000006546 Horner-Wadsworth-Emmons reaction Methods 0.000 description 1
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical group OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- 229910010084 LiAlH4 Inorganic materials 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- XOGTZOOQQBDUSI-UHFFFAOYSA-M Mesna Chemical compound [Na+].[O-]S(=O)(=O)CCS XOGTZOOQQBDUSI-UHFFFAOYSA-M 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Chemical group OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 241000235526 Mucor racemosus Species 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 101100513046 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) eth-1 gene Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229910020667 PBr3 Inorganic materials 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- STSCVKRWJPWALQ-UHFFFAOYSA-N TRIFLUOROACETIC ACID ETHYL ESTER Chemical compound CCOC(=O)C(F)(F)F STSCVKRWJPWALQ-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 229910010066 TiC14 Inorganic materials 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 241000748245 Villanova Species 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- LIAGTEFTMYPSRZ-UHFFFAOYSA-N [4,5-dihydroxy-6-[2-methyl-1-[(4-pentylpyrrolidine-2-carbonyl)amino]propyl]-2-propyloxan-3-yl] dihydrogen phosphate Chemical compound C1C(CCCCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(OP(O)(O)=O)C(CCC)O1 LIAGTEFTMYPSRZ-UHFFFAOYSA-N 0.000 description 1
- JNOLRCFZNMPDIO-UHFFFAOYSA-N [4,5-dihydroxy-6-[2-methyl-1-[(4-pentylpyrrolidine-2-carbonyl)amino]propyl]-2-propyloxan-3-yl] hexadecanoate Chemical compound OC1C(O)C(OC(=O)CCCCCCCCCCCCCCC)C(CCC)OC1C(C(C)C)NC(=O)C1NCC(CCCCC)C1 JNOLRCFZNMPDIO-UHFFFAOYSA-N 0.000 description 1
- AZFCXGNLOCDOJB-UHFFFAOYSA-N [4,5-dihydroxy-6-[2-methyl-1-[(4-propylpyrrolidine-2-carbonyl)amino]propyl]-2-propyloxan-3-yl] dihydrogen phosphate Chemical compound C1C(CCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(OP(O)(O)=O)C(CCC)O1 AZFCXGNLOCDOJB-UHFFFAOYSA-N 0.000 description 1
- IBWQQAGVOVLECJ-UHFFFAOYSA-N [4,5-dihydroxy-6-[2-methyl-1-[(4-propylpyrrolidine-2-carbonyl)amino]propyl]-2-propyloxan-3-yl] hexadecanoate Chemical compound OC1C(O)C(OC(=O)CCCCCCCCCCCCCCC)C(CCC)OC1C(C(C)C)NC(=O)C1NCC(CCC)C1 IBWQQAGVOVLECJ-UHFFFAOYSA-N 0.000 description 1
- PJAIRCFEKPCWHY-UHFFFAOYSA-N [6-[2-chloro-1-[(4-fluoro-4-propylpiperidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate Chemical compound C1C(CCC)(F)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(OP(O)(O)=O)C(SC)O1 PJAIRCFEKPCWHY-UHFFFAOYSA-N 0.000 description 1
- KZCMXQCUJQVHEX-UHFFFAOYSA-N [6-[2-chloro-1-[(4-fluoro-4-propylpiperidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate Chemical compound O1C(SC)C(OC(=O)CCCCCCCCCCCCCCC)C(O)C(O)C1C(C(C)Cl)NC(=O)C1NCCC(F)(CCC)C1 KZCMXQCUJQVHEX-UHFFFAOYSA-N 0.000 description 1
- WXMKEDHDRCJXMX-UHFFFAOYSA-N [6-[2-chloro-1-[(5-fluoro-5-propylazepane-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate Chemical compound C1CC(CCC)(F)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(OP(O)(O)=O)C(SC)O1 WXMKEDHDRCJXMX-UHFFFAOYSA-N 0.000 description 1
- AAZJFEAFVOXPRJ-UHFFFAOYSA-N [6-[2-chloro-1-[(5-fluoro-5-propylazepane-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate Chemical compound O1C(SC)C(OC(=O)CCCCCCCCCCCCCCC)C(O)C(O)C1C(C(C)Cl)NC(=O)C1NCCC(F)(CCC)CC1 AAZJFEAFVOXPRJ-UHFFFAOYSA-N 0.000 description 1
- VZXJDJJXAKSUMN-UHFFFAOYSA-N [6-[2-chloro-1-[(5-propylazepane-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate Chemical compound C1CC(CCC)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(OP(O)(O)=O)C(SC)O1 VZXJDJJXAKSUMN-UHFFFAOYSA-N 0.000 description 1
- KLKVEPCCSKYZHJ-UHFFFAOYSA-N [6-[2-chloro-1-[(5-propylazepane-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate Chemical compound O1C(SC)C(OC(=O)CCCCCCCCCCCCCCC)C(O)C(O)C1C(C(C)Cl)NC(=O)C1NCCC(CCC)CC1 KLKVEPCCSKYZHJ-UHFFFAOYSA-N 0.000 description 1
- SWLXTVSLIMVWFW-UHFFFAOYSA-N [6-[2-chloro-1-[[5-(cyclopropylmethyl)azepane-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate Chemical compound OC1C(O)C(OP(O)(O)=O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCCC(CC2CC2)CC1 SWLXTVSLIMVWFW-UHFFFAOYSA-N 0.000 description 1
- DCGQVMFFLFURJM-UHFFFAOYSA-N [6-[2-chloro-1-[[5-(cyclopropylmethyl)azepane-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate Chemical compound O1C(SC)C(OC(=O)CCCCCCCCCCCCCCC)C(O)C(O)C1C(C(C)Cl)NC(=O)C1NCCC(CC2CC2)CC1 DCGQVMFFLFURJM-UHFFFAOYSA-N 0.000 description 1
- PXVYKHUQICALGJ-UHFFFAOYSA-L [Cs+].[Cs+].[O-]C([O-])=O.CCN(CC)CC Chemical compound [Cs+].[Cs+].[O-]C([O-])=O.CCN(CC)CC PXVYKHUQICALGJ-UHFFFAOYSA-L 0.000 description 1
- SORGEQQSQGNZFI-UHFFFAOYSA-N [azido(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(N=[N+]=[N-])OC1=CC=CC=C1 SORGEQQSQGNZFI-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- PWQLZSHJRGGLBC-UHFFFAOYSA-N acetonitrile;carbon dioxide Chemical compound CC#N.O=C=O PWQLZSHJRGGLBC-UHFFFAOYSA-N 0.000 description 1
- AUALQMFGWLZREY-UHFFFAOYSA-N acetonitrile;methanol Chemical compound OC.CC#N AUALQMFGWLZREY-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 229940081735 acetylcellulose Drugs 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000002814 agar dilution Methods 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 229910001420 alkaline earth metal ion Inorganic materials 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 238000005937 allylation reaction Methods 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 125000000266 alpha-aminoacyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 238000009635 antibiotic susceptibility testing Methods 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 150000001537 azepanes Chemical class 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 150000004051 azocanes Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- MYONAGGJKCJOBT-UHFFFAOYSA-N benzimidazol-2-one Chemical compound C1=CC=CC2=NC(=O)N=C21 MYONAGGJKCJOBT-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 229960003340 calcium silicate Drugs 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 125000005518 carboxamido group Chemical group 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 210000004289 cerebral ventricle Anatomy 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000010568 chiral column chromatography Methods 0.000 description 1
- 208000028512 chlamydia infectious disease Diseases 0.000 description 1
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical compound C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- LTUTVFXOEGMHMP-UHFFFAOYSA-N dibromofluoromethane Chemical compound FC(Br)Br LTUTVFXOEGMHMP-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- YNLAOSYQHBDIKW-UHFFFAOYSA-M diethylaluminium chloride Chemical compound CC[Al](Cl)CC YNLAOSYQHBDIKW-UHFFFAOYSA-M 0.000 description 1
- HQWPLXHWEZZGKY-UHFFFAOYSA-N diethylzinc Chemical compound CC[Zn]CC HQWPLXHWEZZGKY-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940113088 dimethylacetamide Drugs 0.000 description 1
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical group CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 229940112141 dry powder inhaler Drugs 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- UZRDREPVAWXHDU-UHFFFAOYSA-N ethyl 2-[[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]carbamoyl]-4-propylpiperidine-1-carboxylate Chemical compound C1C(CCC)CCN(C(=O)OCC)C1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 UZRDREPVAWXHDU-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 239000012054 flavored emulsion Substances 0.000 description 1
- 235000020375 flavoured syrup Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Chemical group 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Chemical group 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- KUCDOJMOTMEEOF-UHFFFAOYSA-N gtpl6345 Chemical compound C1=CC(OC)=CC=C1N1C(=O)C(SC=2C3=C4NCCOC4=CN=2)=C3N=C1 KUCDOJMOTMEEOF-UHFFFAOYSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical class [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 238000006197 hydroboration reaction Methods 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000000819 hypertonic solution Substances 0.000 description 1
- 229940021223 hypertonic solution Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- HOBCFUWDNJPFHB-UHFFFAOYSA-N indolizine Chemical compound C1=CC=CN2C=CC=C21 HOBCFUWDNJPFHB-UHFFFAOYSA-N 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- HEBMCVBCEDMUOF-UHFFFAOYSA-N isochromane Chemical compound C1=CC=C2COCCC2=C1 HEBMCVBCEDMUOF-UHFFFAOYSA-N 0.000 description 1
- GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical compound C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 description 1
- CPJRRXSHAYUTGL-UHFFFAOYSA-N isopentenyl alcohol Chemical compound CC(=C)CCO CPJRRXSHAYUTGL-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000001115 mace Substances 0.000 description 1
- CCERQOYLJJULMD-UHFFFAOYSA-M magnesium;carbanide;chloride Chemical compound [CH3-].[Mg+2].[Cl-] CCERQOYLJJULMD-UHFFFAOYSA-M 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229960004635 mesna Drugs 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- QJGYZJVCWOMBJW-UHFFFAOYSA-N methyl 2-[2-[[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]carbamoyl]-4-pentylpyrrolidin-1-yl]acetate Chemical compound COC(=O)CN1CC(CCCCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC)O1 QJGYZJVCWOMBJW-UHFFFAOYSA-N 0.000 description 1
- CFBZKDDOUUEFLB-UHFFFAOYSA-N methyl azepane-1-carboxylate Chemical class COC(=O)N1CCCCCC1 CFBZKDDOUUEFLB-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- SFDZETWZUCDYMD-UHFFFAOYSA-N monosodium acetylide Chemical compound [Na+].[C-]#C SFDZETWZUCDYMD-UHFFFAOYSA-N 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- HVOYZOQVDYHUPF-UHFFFAOYSA-N n,n',n'-trimethylethane-1,2-diamine Chemical compound CNCCN(C)C HVOYZOQVDYHUPF-UHFFFAOYSA-N 0.000 description 1
- FNPXAEAJOCLTEZ-UHFFFAOYSA-N n-[(4-chlorophenyl)-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)methyl]-4-propylpiperidine-2-carboxamide Chemical compound C1C(CCC)CCNC1C(=O)NC(C=1C=CC(Cl)=CC=1)C1C(O)C(O)C(O)C(SC)O1 FNPXAEAJOCLTEZ-UHFFFAOYSA-N 0.000 description 1
- GUDVDKMDLVTWRX-UHFFFAOYSA-N n-[(4-chlorophenyl)-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)methyl]-5-propylazepane-2-carboxamide Chemical compound C1CC(CCC)CCNC1C(=O)NC(C=1C=CC(Cl)=CC=1)C1C(O)C(O)C(O)C(SC)O1 GUDVDKMDLVTWRX-UHFFFAOYSA-N 0.000 description 1
- SFAPNAFXCFKSJI-UHFFFAOYSA-N n-[1-(6-butoxy-3,4,5-trihydroxyoxan-2-yl)-2-methylpropyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound C1C(CCCCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(OCCCC)O1 SFAPNAFXCFKSJI-UHFFFAOYSA-N 0.000 description 1
- ZLAOMJXXIMXPFT-UHFFFAOYSA-N n-[1-(6-tert-butylsulfanyl-3,4,5-trihydroxyoxan-2-yl)-2-methylpropyl]-1-methyl-4-propylpyrrolidine-2-carboxamide Chemical compound CN1CC(CCC)CC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC(C)(C)C)O1 ZLAOMJXXIMXPFT-UHFFFAOYSA-N 0.000 description 1
- OJGIIFXADWWGJL-UHFFFAOYSA-N n-[1-(6-tert-butylsulfanyl-3,4,5-trihydroxyoxan-2-yl)-2-methylpropyl]-4-propylpiperidine-2-carboxamide Chemical compound C1C(CCC)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC(C)(C)C)O1 OJGIIFXADWWGJL-UHFFFAOYSA-N 0.000 description 1
- IILFYPZVGYQYFN-UHFFFAOYSA-N n-[1-(6-tert-butylsulfanyl-3,4,5-trihydroxyoxan-2-yl)-2-methylpropyl]-5-propylazepane-2-carboxamide Chemical compound C1CC(CCC)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC(C)(C)C)O1 IILFYPZVGYQYFN-UHFFFAOYSA-N 0.000 description 1
- XDKJWJSGKHLPHF-UHFFFAOYSA-N n-[1-[6-(2-ethoxyethyl)-3,4,5-trihydroxyoxan-2-yl]-2-methylpropyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound C1C(CCCCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CCOCC)O1 XDKJWJSGKHLPHF-UHFFFAOYSA-N 0.000 description 1
- HCFRXDXGDYLNKB-UHFFFAOYSA-N n-[1-[6-(cyclopropylmethyl)-3,4,5-trihydroxyoxan-2-yl]-2-methylpropyl]-4-propylpyrrolidine-2-carboxamide Chemical compound C1C(CCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CC2CC2)O1 HCFRXDXGDYLNKB-UHFFFAOYSA-N 0.000 description 1
- WKLYYYFMIDWFAY-UHFFFAOYSA-N n-[1-[6-(ethoxymethyl)-3,4,5-trihydroxyoxan-2-yl]-2-methylpropyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound C1C(CCCCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(COCC)O1 WKLYYYFMIDWFAY-UHFFFAOYSA-N 0.000 description 1
- XUSFOQWJJBYUQX-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-1-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-5-propylazepane-2-carboxamide Chemical compound C1CC(CCC)CCC(C(=O)NC(C(C)Cl)C2C(C(O)C(O)C(SC)O2)O)N1CC=1OC(=O)OC=1C XUSFOQWJJBYUQX-UHFFFAOYSA-N 0.000 description 1
- XLNNBHCKTXTCIT-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-3-(2-cyclobutylethyl)azetidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1C(CCC2CCC2)CN1 XLNNBHCKTXTCIT-UHFFFAOYSA-N 0.000 description 1
- XDLPJKNAUSHXKC-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-3-(2-cyclopropylethyl)azetidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1C(CCC2CC2)CN1 XDLPJKNAUSHXKC-UHFFFAOYSA-N 0.000 description 1
- ZRFLECCTJLQRPR-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-3-(3,3-difluoropropyl)azetidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1C(CCC(F)F)CN1 ZRFLECCTJLQRPR-UHFFFAOYSA-N 0.000 description 1
- JDJBGDJTWVWKGG-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-3-(3-cyclopropylpropyl)azetidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1C(CCCC2CC2)CN1 JDJBGDJTWVWKGG-UHFFFAOYSA-N 0.000 description 1
- OCNIGBIKASAIRC-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-3-(3-methylbutyl)azetidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1C(CCC(C)C)CN1 OCNIGBIKASAIRC-UHFFFAOYSA-N 0.000 description 1
- JPOPDFDIUYRCJS-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-3-pentylazetidine-2-carboxamide Chemical compound CCCCCC1CNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 JPOPDFDIUYRCJS-UHFFFAOYSA-N 0.000 description 1
- UWDLWNHQTLHWAL-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-3-propylazetidine-2-carboxamide Chemical compound CCCC1CNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 UWDLWNHQTLHWAL-UHFFFAOYSA-N 0.000 description 1
- JJLGDBJIQCVHAU-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(2-cyclobutylethyl)piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCCC(CCC2CCC2)C1 JJLGDBJIQCVHAU-UHFFFAOYSA-N 0.000 description 1
- VHDZVMQUPLNISA-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(2-cyclobutylethyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCC(CCC2CCC2)C1 VHDZVMQUPLNISA-UHFFFAOYSA-N 0.000 description 1
- SRVZSYVCSMVUNJ-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(2-cyclobutylideneethyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCC(CC=C2CCC2)C1 SRVZSYVCSMVUNJ-UHFFFAOYSA-N 0.000 description 1
- PNCFHBJDSKAXBS-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(2-cyclopropylethyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCC(CCC2CC2)C1 PNCFHBJDSKAXBS-UHFFFAOYSA-N 0.000 description 1
- XMTAUQGPNDCSKR-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(cyclopropylmethyl)-4-fluoropiperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCCC(F)(CC2CC2)C1 XMTAUQGPNDCSKR-UHFFFAOYSA-N 0.000 description 1
- LBEISHXSIBIHME-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(cyclopropylmethyl)piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCCC(CC2CC2)C1 LBEISHXSIBIHME-UHFFFAOYSA-N 0.000 description 1
- QDEOIFYJYVIITD-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(cyclopropylmethyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCC(CC2CC2)C1 QDEOIFYJYVIITD-UHFFFAOYSA-N 0.000 description 1
- DLPDEOJDPWNYGU-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-ethyl-4-fluoropiperidine-2-carboxamide Chemical compound C1C(CC)(F)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 DLPDEOJDPWNYGU-UHFFFAOYSA-N 0.000 description 1
- GXCCJSBRRHOFPR-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-ethyl-5-methylazepane-2-carboxamide Chemical compound N1CCC(C)C(CC)CC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 GXCCJSBRRHOFPR-UHFFFAOYSA-N 0.000 description 1
- YMNOUVTXAWFNQD-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-fluoro-1-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-4-propylpiperidine-2-carboxamide Chemical compound O1C(SC)C(O)C(O)C(O)C1C(C(C)Cl)NC(=O)C1CC(CCC)(F)CCN1CC=1OC(=O)OC=1C YMNOUVTXAWFNQD-UHFFFAOYSA-N 0.000 description 1
- FPMGQPCEYFNJEM-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-fluoro-4-propylpyrrolidine-2-carboxamide Chemical compound C1C(CCC)(F)CNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 FPMGQPCEYFNJEM-UHFFFAOYSA-N 0.000 description 1
- YYSNMEHCWYBQCE-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-methyl-5-propylazepane-2-carboxamide Chemical compound C1C(C)C(CCC)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 YYSNMEHCWYBQCE-UHFFFAOYSA-N 0.000 description 1
- OFGBGSARZVYJST-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-propylazepane-2-carboxamide Chemical compound C1C(CCC)CCCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 OFGBGSARZVYJST-UHFFFAOYSA-N 0.000 description 1
- XRNNKODPCJKVGW-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-5-(cyclopropylmethyl)-1-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]azepane-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1N(CC2=C(OC(=O)O2)C)CCC(CC2CC2)CC1 XRNNKODPCJKVGW-UHFFFAOYSA-N 0.000 description 1
- ROWREGOWFOGPFD-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-5-cyclopropylazepane-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCCC(C2CC2)CC1 ROWREGOWFOGPFD-UHFFFAOYSA-N 0.000 description 1
- ACLQIUGLPHLMNV-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-5-ethyl-4-methylazepane-2-carboxamide Chemical compound C1C(C)C(CC)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 ACLQIUGLPHLMNV-UHFFFAOYSA-N 0.000 description 1
- OWUFAZIEPCEMOK-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-5-ethyl-6-methylazepane-2-carboxamide Chemical compound N1CC(C)C(CC)CCC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 OWUFAZIEPCEMOK-UHFFFAOYSA-N 0.000 description 1
- XOTHJWRGWHXRMV-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-5-fluoro-1-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-5-propylazepane-2-carboxamide Chemical compound C1CC(CCC)(F)CCC(C(=O)NC(C(C)Cl)C2C(C(O)C(O)C(SC)O2)O)N1CC=1OC(=O)OC=1C XOTHJWRGWHXRMV-UHFFFAOYSA-N 0.000 description 1
- QUFFGAFHMJTPCB-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-5-fluoro-5-propylazepane-2-carboxamide Chemical compound C1CC(CCC)(F)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 QUFFGAFHMJTPCB-UHFFFAOYSA-N 0.000 description 1
- JLZWBUFHJLMTDC-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-5-methylazepane-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)Cl)NC(=O)C1NCCC(C)CC1 JLZWBUFHJLMTDC-UHFFFAOYSA-N 0.000 description 1
- DDHCADLFGXICPU-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-5-pentylazepane-2-carboxamide Chemical compound C1CC(CCCCC)CCNC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 DDHCADLFGXICPU-UHFFFAOYSA-N 0.000 description 1
- MGVDNRQGUPUSCV-UHFFFAOYSA-N n-[2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-5-propyl-2,3,6,7-tetrahydro-1h-azepine-2-carboxamide Chemical compound N1CCC(CCC)=CCC1C(=O)NC(C(C)Cl)C1C(O)C(O)C(O)C(SC)O1 MGVDNRQGUPUSCV-UHFFFAOYSA-N 0.000 description 1
- DZWARKMMNMLORV-UHFFFAOYSA-N n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(3,3,3-trifluoropropylsulfanyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCCC(F)(F)F)C1 DZWARKMMNMLORV-UHFFFAOYSA-N 0.000 description 1
- YQRAVPQGKCBDCK-UHFFFAOYSA-N n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(3-methylbutylsulfanyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCCC(C)C)C1 YQRAVPQGKCBDCK-UHFFFAOYSA-N 0.000 description 1
- GCBGCRVFIGNWLR-UHFFFAOYSA-N n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(pyrazin-2-ylmethylsulfanyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCC=2N=CC=NC=2)C1 GCBGCRVFIGNWLR-UHFFFAOYSA-N 0.000 description 1
- QISPYBSUSXGYPY-UHFFFAOYSA-N n-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(pyridin-2-ylmethylsulfanyl)pyrrolidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)O)NC(=O)C1NCC(SCC=2N=CC=CC=2)C1 QISPYBSUSXGYPY-UHFFFAOYSA-N 0.000 description 1
- NBTVKZAHDVVTCW-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-(pyrrol-1-ylmethyl)piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CN2C=CC=C2)C1 NBTVKZAHDVVTCW-UHFFFAOYSA-N 0.000 description 1
- ADZCSXXLFDMSBV-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-[2-(triazol-1-yl)ethyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCN2N=NC=C2)C1 ADZCSXXLFDMSBV-UHFFFAOYSA-N 0.000 description 1
- PTBVYWPTUFDVAQ-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-4-[3-(2-oxopyrrolidin-1-yl)propyl]piperidine-2-carboxamide Chemical compound OC1C(O)C(O)C(SC)OC1C(C(C)C)NC(=O)C1NCCC(CCCN2C(CCC2)=O)C1 PTBVYWPTUFDVAQ-UHFFFAOYSA-N 0.000 description 1
- GNZZOZGHYUXMAP-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-propan-2-ylsulfanyloxan-2-yl)propyl]-4-propylpiperidine-2-carboxamide Chemical compound C1C(CCC)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC(C)C)O1 GNZZOZGHYUXMAP-UHFFFAOYSA-N 0.000 description 1
- UGSLYDQPXACYFQ-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-propan-2-ylsulfanyloxan-2-yl)propyl]-5-propylazepane-2-carboxamide Chemical compound C1CC(CCC)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SC(C)C)O1 UGSLYDQPXACYFQ-UHFFFAOYSA-N 0.000 description 1
- SZOJVKWLQWSYCL-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-propyloxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound C1C(CCCCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CCC)O1 SZOJVKWLQWSYCL-UHFFFAOYSA-N 0.000 description 1
- NSKMMGDLZOZZNL-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxy-6-propyloxan-2-yl)propyl]-4-propylpiperidine-2-carboxamide Chemical compound C1C(CCC)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CCC)O1 NSKMMGDLZOZZNL-UHFFFAOYSA-N 0.000 description 1
- LMWCAOHYAYDOSH-UHFFFAOYSA-N n-[2-methyl-1-(3,4,5-trihydroxyoxan-2-yl)propyl]-4-pentylpyrrolidine-2-carboxamide Chemical compound C1C(CCCCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)CO1 LMWCAOHYAYDOSH-UHFFFAOYSA-N 0.000 description 1
- XDQUESJFVGUIND-UHFFFAOYSA-N n-[2-methyl-1-[3,4,5-trihydroxy-6-(2,2,2-trifluoroethylsulfanyl)oxan-2-yl]propyl]-4-propylpiperidine-2-carboxamide Chemical compound C1C(CCC)CCNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(SCC(F)(F)F)O1 XDQUESJFVGUIND-UHFFFAOYSA-N 0.000 description 1
- LNUANCSQHIFKNR-UHFFFAOYSA-N n-[2-methyl-1-[3,4,5-trihydroxy-6-(2-hydroxyethyl)oxan-2-yl]propyl]-4-propylpyrrolidine-2-carboxamide Chemical compound C1C(CCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CCO)O1 LNUANCSQHIFKNR-UHFFFAOYSA-N 0.000 description 1
- YKTCRJMDZJEYIR-UHFFFAOYSA-N n-[2-methyl-1-[3,4,5-trihydroxy-6-(2-methylsulfanylethyl)oxan-2-yl]propyl]-4-propylpyrrolidine-2-carboxamide Chemical compound C1C(CCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CCSC)O1 YKTCRJMDZJEYIR-UHFFFAOYSA-N 0.000 description 1
- WRCFHQGUCJQRQD-UHFFFAOYSA-N n-[2-methyl-1-[3,4,5-trihydroxy-6-(3-hydroxypropyl)oxan-2-yl]propyl]-4-propylpyrrolidine-2-carboxamide Chemical compound C1C(CCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CCCO)O1 WRCFHQGUCJQRQD-UHFFFAOYSA-N 0.000 description 1
- FRPCTAZJHCODMF-UHFFFAOYSA-N n-[2-methyl-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]propyl]-4-propylpyrrolidine-2-carboxamide Chemical compound C1C(CCC)CNC1C(=O)NC(C(C)C)C1C(O)C(O)C(O)C(CO)O1 FRPCTAZJHCODMF-UHFFFAOYSA-N 0.000 description 1
- JSOJXRFXOZYQQY-UHFFFAOYSA-N n-[cyclopentyl-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)methyl]-4-propylpiperidine-2-carboxamide Chemical compound C1C(CCC)CCNC1C(=O)NC(C1C(C(O)C(O)C(SC)O1)O)C1CCCC1 JSOJXRFXOZYQQY-UHFFFAOYSA-N 0.000 description 1
- SDSSYLGILMURIY-UHFFFAOYSA-N n-[cyclopentyl-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)methyl]-5-propylazepane-2-carboxamide Chemical compound C1CC(CCC)CCNC1C(=O)NC(C1C(C(O)C(O)C(SC)O1)O)C1CCCC1 SDSSYLGILMURIY-UHFFFAOYSA-N 0.000 description 1
- JZPMXQXPMVHSGN-UHFFFAOYSA-N n-[cyclopropyl-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)methyl]-1-methyl-4-propylpyrrolidine-2-carboxamide Chemical compound CN1CC(CCC)CC1C(=O)NC(C1C(C(O)C(O)C(SC)O1)O)C1CC1 JZPMXQXPMVHSGN-UHFFFAOYSA-N 0.000 description 1
- RTOCJIWYFOYZQQ-UHFFFAOYSA-N n-[phenyl-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)methyl]-4-propylpiperidine-2-carboxamide Chemical compound C1C(CCC)CCNC1C(=O)NC(C=1C=CC=CC=1)C1C(O)C(O)C(O)C(SC)O1 RTOCJIWYFOYZQQ-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- SQDFHQJTAWCFIB-UHFFFAOYSA-N n-methylidenehydroxylamine Chemical compound ON=C SQDFHQJTAWCFIB-UHFFFAOYSA-N 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000012434 nucleophilic reagent Substances 0.000 description 1
- 239000012053 oil suspension Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000006772 olefination reaction Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- LVSJDHGRKAEGLX-UHFFFAOYSA-N oxolane;2,2,2-trifluoroacetic acid Chemical compound C1CCOC1.OC(=O)C(F)(F)F LVSJDHGRKAEGLX-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Chemical group OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- IPNPIHIZVLFAFP-UHFFFAOYSA-N phosphorus tribromide Chemical compound BrP(Br)Br IPNPIHIZVLFAFP-UHFFFAOYSA-N 0.000 description 1
- SFLGSKRGOWRGBR-UHFFFAOYSA-N phthalane Chemical compound C1=CC=C2COCC2=C1 SFLGSKRGOWRGBR-UHFFFAOYSA-N 0.000 description 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 239000003880 polar aprotic solvent Substances 0.000 description 1
- WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 150000003141 primary amines Chemical group 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 description 1
- CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- VGGUKFAVHPGNBF-UHFFFAOYSA-N s-ethyl 2,2,2-trifluoroethanethioate Chemical compound CCSC(=O)C(F)(F)F VGGUKFAVHPGNBF-UHFFFAOYSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000012058 sterile packaged powder Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000002653 sulfanylmethyl group Chemical group [H]SC([H])([H])[*] 0.000 description 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
- 150000003457 sulfones Chemical group 0.000 description 1
- 230000006103 sulfonylation Effects 0.000 description 1
- 238000005694 sulfonylation reaction Methods 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- OSBSFAARYOCBHB-UHFFFAOYSA-N tetrapropylammonium Chemical compound CCC[N+](CCC)(CCC)CCC OSBSFAARYOCBHB-UHFFFAOYSA-N 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- CMSYDJVRTHCWFP-UHFFFAOYSA-N triphenylphosphane;hydrobromide Chemical compound Br.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 CMSYDJVRTHCWFP-UHFFFAOYSA-N 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229910009112 xH2O Inorganic materials 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
- C07H15/16—Lincomycin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/992,564 | 2004-11-17 | ||
| US10/992,564 US7256177B2 (en) | 2003-06-17 | 2004-11-17 | Lincomycin derivatives possessing antibacterial activity |
| US11/217,836 | 2005-08-31 | ||
| US11/217,836 US7361743B2 (en) | 2004-02-11 | 2005-08-31 | Lincomycin derivatives possessing antibacterial activity |
| PCT/US2005/031615 WO2006055070A2 (en) | 2004-11-17 | 2005-09-01 | Novel lincomycin derivatives possessing antibacterial activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2587797A1 true CA2587797A1 (en) | 2006-05-26 |
Family
ID=36407579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002587797A Abandoned CA2587797A1 (en) | 2004-11-17 | 2005-09-01 | Novel lincomycin derivatives possessing antibacterial activity |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7361743B2 (enExample) |
| EP (1) | EP1814893A2 (enExample) |
| JP (1) | JP2008520662A (enExample) |
| CA (1) | CA2587797A1 (enExample) |
| WO (1) | WO2006055070A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1970377A4 (en) * | 2005-12-09 | 2013-02-27 | Meiji Seika Kaisha | LINCOMYCIN DERIVATIVE AND ANTIBACTERIAL AGENT CONTAINING THIS AS AN ACTIVE SUBSTANCE |
| US9187485B2 (en) | 2007-02-02 | 2015-11-17 | Baylor College Of Medicine | Methods and compositions for the treatment of cancer and related hyperproliferative disorders |
| EP2166015A4 (en) * | 2007-05-31 | 2012-09-05 | Meiji Seika Kaisha | LINCOSAMIDE DERIVATIVE AND ANTIBACTERIAL AGENT CONTAINING ACTIVE SUBSTANCE |
| EP2151447A4 (en) * | 2007-05-31 | 2012-09-05 | Meiji Seika Kaisha | LINCOMYCIN DERIVATIVES AND ANTIBACTERIAL AGENTS CONTAINING SAME AS ACTIVE INGREDIENTS |
| CN102964400B (zh) * | 2012-11-20 | 2015-08-05 | 广州白云山天心制药股份有限公司 | 一种不含去氢林可霉素的盐酸林可霉素制备方法 |
| US9856214B2 (en) | 2013-11-15 | 2018-01-02 | The Wistar Institute Of Anatomy And Biology | EBNA1 inhibitors and their method of use |
| CN104897896B (zh) * | 2015-04-14 | 2016-08-24 | 北京勤邦生物技术有限公司 | 一种林可霉素的磁免疫化学发光检测试剂盒及其应用 |
| JP6771491B2 (ja) | 2015-05-14 | 2020-10-21 | ザ ウィスター インスティテュート オブ アナトミー アンド バイオロジー | Ebna1阻害剤およびその使用方法 |
| CN104829660B (zh) * | 2015-05-27 | 2018-04-10 | 重庆药友制药有限责任公司 | 一种克林霉素磷酸酯的同分异构体 |
| JP6744622B2 (ja) * | 2016-06-16 | 2020-08-19 | 学校法人上智学院 | ピペリジン化合物の製造方法 |
| WO2019032941A1 (en) * | 2017-08-10 | 2019-02-14 | President And Fellows Of Harvard College | NOVEL LINCOSAMIDE ANTIBIOTICS AND CORRESPONDING USES THEREOF |
| US11566039B2 (en) | 2017-08-10 | 2023-01-31 | President And Fellows Of Harvard College | Lincosamide antibiotics and uses thereof |
| WO2019032936A1 (en) | 2017-08-10 | 2019-02-14 | President Adn Fellows Of Harvard College | LINCONSAMIDE ANTIBIOTICS AND USES THEREOF |
| TW201946919A (zh) | 2018-05-17 | 2019-12-16 | 威斯塔研究所 | Ebna1抑制劑晶形、其製備方法及其使用方法 |
| EP3608326A1 (en) | 2018-08-10 | 2020-02-12 | Irbm S.P.A. | Tricyclic inhibitors of hepatitis b virus |
| EP4511043A1 (en) * | 2022-04-20 | 2025-02-26 | President and Fellows of Harvard College | Lincosamides and uses thereof |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2851463A (en) | 1956-04-09 | 1958-09-09 | Upjohn Co | Desalicetin and salts, and hydrocarbon carboxylic acid esters |
| US2928844A (en) | 1958-02-24 | 1960-03-15 | Upjohn Co | Celesticetin, its salts and method of preparation |
| US3086912A (en) | 1961-07-03 | 1963-04-23 | Upjohn Co | Antibiotic lincolnensin and method of production |
| US3268556A (en) | 1964-04-13 | 1966-08-23 | Upjohn Co | Novel lincomycin derivatives |
| US3255174A (en) | 1964-04-13 | 1966-06-07 | Upjohn Co | 7-0-methyl-n-acyl-3, 4-o-isopropylidene-1-deoxy-lincosamines |
| NL128232C (enExample) | 1964-04-13 | |||
| NL146501C (enExample) | 1964-07-01 | |||
| US3764672A (en) | 1964-08-05 | 1973-10-09 | Upjohn Co | Composition and process of treatment using lincomycin derivatives |
| US3380992A (en) | 1965-06-14 | 1968-04-30 | Upjohn Co | Lincomycin derivatives and process for preparing same |
| US3282917A (en) | 1964-08-17 | 1966-11-01 | Upjohn Co | Methyl n-(1-alkyl-4-alkoxy-prolyl)-alpha-thiolincosaminide compounds and process therefor |
| US3502648A (en) | 1965-02-08 | 1970-03-24 | Upjohn Co | 7-halo-7-deoxythiolincosaminides and process for preparing the same |
| NL140527B (nl) | 1965-02-08 | 1973-12-17 | Upjohn Co | Werkwijze ter bereiding van aan lincomycine verwante verbindingen. |
| US3496163A (en) | 1965-02-08 | 1970-02-17 | Upjohn Co | 7-halo-7-deoxylincomycins and process for preparing the same |
| US3435025A (en) | 1966-03-18 | 1969-03-25 | Upjohn Co | 7-deoxylincomycin and analogs and isomers thereof and process for making the same |
| US3475407A (en) | 1967-12-22 | 1969-10-28 | Upjohn Co | Process for preparing 7(r)- and 7(s)-halolincomycins |
| US3509127A (en) | 1968-04-30 | 1970-04-28 | Upjohn Co | Isologs of lincomycins and process for preparing the same |
| US3544551A (en) | 1968-04-30 | 1970-12-01 | Upjohn Co | 7-mercapto-7-deoxylincomycins and process for preparing the same |
| US3555007A (en) | 1968-07-22 | 1971-01-12 | Upjohn Co | 7-deoxy-7-halo lincomycin d derivatives |
| US3549615A (en) | 1968-10-17 | 1970-12-22 | Upjohn Co | Lincomycin derivatives and process for producing the same |
| US3702322A (en) | 1970-04-06 | 1972-11-07 | Upjohn Co | Derivatives of lincomycin and its analogs and process |
| DE2118636A1 (de) | 1970-04-20 | 1971-11-04 | The Upjohn Co., Kalamazoo, Mich. (V.StA.) | 3-Nucleotide von Lincomycin und deren Analogen, Verfahren zu ihrer Herstellung und ihre Verwendung in therapeutischen Präparaten |
| US3692767A (en) | 1970-05-06 | 1972-09-19 | Upjohn Co | Process for making lincomycin and analogs thereof and novel compounds obtained thereby |
| US3714141A (en) | 1970-05-26 | 1973-01-30 | Upjohn Co | Process for making 7-halolincomycins |
| US3674647A (en) | 1970-10-07 | 1972-07-04 | Upjohn Co | Preparation of lincomycin analogues |
| US3715346A (en) | 1970-11-18 | 1973-02-06 | Upjohn Co | Process for the preparation of lincomycin compounds |
| US3671647A (en) | 1971-03-24 | 1972-06-20 | Upjohn Co | Lincomycin 3-nucleotides and the salts thereof |
| US3892729A (en) | 1971-06-23 | 1975-07-01 | Upjohn Co | 1{40 (Beta-hydroxyethyl)-1{40 -demethyl clindamycin 2-phosphates |
| US3787390A (en) | 1971-06-23 | 1974-01-22 | Upjohn Co | Analogs of lincomycin and process |
| US3892730A (en) | 1971-06-23 | 1975-07-01 | Upjohn Co | 1{40 -({62 -hydroxyethyl)-1{40 -demethyl clindamycin 2-acylates |
| US3856943A (en) | 1971-06-23 | 1974-12-24 | Upjohn Co | Compositions and process |
| US3915954A (en) | 1971-11-15 | 1975-10-28 | Upjohn Co | Derivatives of lincomycin and its analogs and process |
| BE793630A (fr) | 1972-01-03 | 1973-07-03 | Upjohn Co | Nouvel antibiotique de la classe des celesticetines et son procede de preparation |
| US3853843A (en) | 1972-12-13 | 1974-12-10 | Upjohn Co | Derivatives of thiolincosaminide compounds |
| US3849396A (en) | 1973-01-08 | 1974-11-19 | Upjohn Co | Lincomycin and clindamycin 1-o-ethers |
| US3870699A (en) | 1973-03-06 | 1975-03-11 | Upjohn Co | Lincomycin analogs |
| US3833475A (en) | 1973-04-23 | 1974-09-03 | Upjohn Co | Process for preparing lincomycin |
| US4271266A (en) | 1974-06-10 | 1981-06-02 | The Upjohn Manufacturing Company | Process for preparing lincomycin |
| US4031304A (en) | 1976-01-30 | 1977-06-21 | The Upjohn Company | Process for preparing lincomycin derivatives |
| US4278789A (en) | 1979-11-23 | 1981-07-14 | The Upjohn Company | Lincomycin compounds |
| US4310660A (en) | 1980-05-19 | 1982-01-12 | The Upjohn Company | Lincomycin compounds |
| US4309533A (en) | 1980-05-19 | 1982-01-05 | The Upjohn Company | Lincomycin compounds |
| US4293547A (en) | 1980-08-25 | 1981-10-06 | The Upjohn Company | Method of treating malaria |
| US4317903A (en) | 1981-01-26 | 1982-03-02 | The Upjohn Company | Process for the purification of lincomycin |
| US4383109A (en) | 1981-04-20 | 1983-05-10 | The Upjohn Company | Lincomycin nucleotides |
| US4464466A (en) | 1981-04-20 | 1984-08-07 | The Upjohn Company | Process of producing lincomycin nucleotides |
| US4430495A (en) | 1982-09-17 | 1984-02-07 | The Upjohn Company | Process for preparing lincomycin and clindamycin ribonucleotides |
| US4568741A (en) | 1984-05-15 | 1986-02-04 | The Upjohn Company | Synthesis of 7-halo-7-deoxylincomycins |
| CN1004002B (zh) | 1984-11-29 | 1989-04-26 | 厄普约翰公司 | 制备7-卤-7-去氧林可霉素及其类似化合物的改进方法 |
| WO1989004672A1 (en) | 1987-11-20 | 1989-06-01 | The Upjohn Company | Derivatives of lincosaminide antibiotics |
| US5182374A (en) * | 1990-03-21 | 1993-01-26 | American Cyanamid Company | Clindamycin phosphate synthesis |
| US6288234B1 (en) | 1998-06-08 | 2001-09-11 | Advanced Medicine, Inc. | Multibinding inhibitors of microsomal triglyceride transferase protein |
| US7164011B2 (en) | 2002-08-15 | 2007-01-16 | Vicuron Pharmaceuticals, Inc. | Lincomycin derivatives possessing antibacterial activity |
| EP1644393A2 (en) | 2003-06-17 | 2006-04-12 | Vicuron Pharmaceuticals, Inc. | Novel lincomycin derivatives possessing antimicrobial activity |
| EP1654268A2 (en) | 2003-06-17 | 2006-05-10 | Vicuron Pharmaceuticals, Inc. | Lincomycin derivatives possessing antibacterial activity |
-
2005
- 2005-08-31 US US11/217,836 patent/US7361743B2/en not_active Expired - Fee Related
- 2005-09-01 JP JP2007543023A patent/JP2008520662A/ja active Pending
- 2005-09-01 CA CA002587797A patent/CA2587797A1/en not_active Abandoned
- 2005-09-01 WO PCT/US2005/031615 patent/WO2006055070A2/en not_active Ceased
- 2005-09-01 EP EP05794095A patent/EP1814893A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006055070A2 (en) | 2006-05-26 |
| EP1814893A2 (en) | 2007-08-08 |
| JP2008520662A (ja) | 2008-06-19 |
| US7361743B2 (en) | 2008-04-22 |
| US20060148722A1 (en) | 2006-07-06 |
| WO2006055070A3 (en) | 2006-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2587797A1 (en) | Novel lincomycin derivatives possessing antibacterial activity | |
| AU2004261550A1 (en) | Novel lincomycin derivatives possessing antimicrobial activity | |
| EP3077387B1 (en) | Benzamide derivative useful as fasn inhibitors for the treatment of cancer | |
| HU223839B1 (hu) | Glikoszfingolipid-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
| AU2003265475B2 (en) | Lincomycin derivatives possessing antibacterial activity | |
| JP2009504631A (ja) | 新規な抗菌剤化合物 | |
| US7256177B2 (en) | Lincomycin derivatives possessing antibacterial activity | |
| US20050043248A1 (en) | Novel lincomycin derivatives possessing antimicrobial activity | |
| US20040230046A1 (en) | Lincomycin derivatives possessing antibacterial activity | |
| EP1654268A2 (en) | Lincomycin derivatives possessing antibacterial activity | |
| CN1823083B (zh) | 具备抗微生物活性的林可霉素衍生物 | |
| KR20090099594A (ko) | 항균 활성을 갖는 신규 린코마이신 유도체 | |
| HK1090061B (en) | Novel lincomycin derivatives possessing antimicrobial activity | |
| MXPA05014064A (en) | Lincomycin derivatives possessing antibacterial activity | |
| JP2007528360A (ja) | 抗菌活性を有するリンコマイシン誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |